Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progesterone receptor modulators and the endometrium: changes and consequences.

Frances McFarland Horne1, Diana L Blithe

  • 1Rose Li & Associates, Inc., Bethesda, MD 20817, USA.

Human Reproduction Update
|July 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine Device.

NEJM evidence·2025
Same author

Consensus recommendations for measuring the impact of contraception on the menstrual cycle in contraceptive clinical trials.

Contraception·2025
Same author

Development of a transdermal gel for reversible male contraception.

Contraception·2025
Same author

Evaluation of dimethandrolone undecanoate in non-human primates as a candidate for long-acting injectable male contraceptive.

Andrology·2024
Same author

Use of at-home sperm concentration testing in a male hormonal contraceptive efficacy clinical trial.

Fertility and sterility·2024
Same author

Identification of the Biotransformation Pathways of a Potential Oral Male Contraceptive, 11β-Methyl-19-Nortestosterone (11β-MNT) and Its Prodrugs: An In Vitro Study Highlights the Contribution of Polymorphic Intestinal UGT2B17.

Pharmaceutics·2024

Long-term use of progesterone receptor modulators (PRMs) causes unique endometrial changes, including glandular dilatation, without safety concerns. Pathologists need standardized descriptions for these PRM-induced histologic alterations.

Area of Science:

  • Reproductive Endocrinology
  • Gynecologic Pathology

Background:

  • Progesterone receptor modulators (PRMs) are utilized in contraceptive research and for treating gynecological conditions like fibroids and endometriosis.
  • Chronic PRM exposure can induce endometrial changes, complicating biopsy interpretation and necessitating a deeper understanding of progesterone receptor biology.
  • A consensus meeting highlighted the need for standardized characterization of PRM-associated endometrial alterations.

Framework:

  • A panel of pathologists evaluated endometrial biopsies from patients undergoing at least three months of chronic PRM treatment.
  • Histologic evaluation was performed by blinded pathologists, unaware of the specific PRM agent or treatment regimen.
  • The study focused on identifying and characterizing morphological changes in the endometrium.

Implementation:

Related Experiment Videos

  • Biopsies exhibited an unusual glandular dilatation architecture, diverging from typical proliferative or secretory classifications.
  • Minimal mitotic activity was observed, supporting the proposed anti-proliferative effects of PRMs.
  • The panel found no evidence of safety concerns associated with these observed endometrial changes.

Implications:

  • Standardized descriptions for PRM-associated endometrial changes are crucial for accurate histologic interpretation.
  • Collaboration between pathologists, researchers, pharmaceutical companies, and regulatory agencies is needed to develop these standards.
  • Clear diagnostic criteria will aid in monitoring patient safety and guiding future PRM development.